What question did this study set out to answer?

This research aims to identify immune signatures linked to remission in ulcerative colitis patients treated with various biologic therapies.

DOP025Single-cell longitudinal profiling of peripheral blood identifies shared and therapy-specific immune signatures of early remission in ulcerative colitis

View Full Paper

Ask AI

Bookmark

Authors

Longitudinal analysis identifies immune signatures in ulcerative colitis patients, suggesting personalized therapy approaches.

This research aims to identify immune signatures linked to remission in ulcerative colitis patients treated with various biologic therapies.
Conducted longitudinal single-cell RNA-sequencing on PBMC samples from 32 ulcerative colitis patients.
Analyzed immune cell proportions and transcriptional profiles over time during treatment.
Utilized differential expression and signaling network analysis to identify treatment-specific immune signatures.
Found increased abundance of conventional dendritic cells, particularly in non-responders.
Responders to anti-TNF and anti-α4β7 therapy exhibited a strong interferon-response in monocytes.
Clinical remission in anti-α4β7 patients correlated with upregulation of innate immune signaling pathways.

Bernardes et al. (2026) studied this question.

View Full Paper

Ask AI

Bookmark